| Product Code: ETC12011406 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The India drug repurposing market is experiencing significant growth due to factors such as the rising prevalence of various diseases, increasing demand for cost-effective treatments, and advancements in drug discovery technologies. Drug repurposing involves finding new therapeutic uses for existing drugs, offering a faster and more cost-effective approach to drug development compared to traditional methods. The market is characterized by collaborations between pharmaceutical companies, research institutions, and government organizations to explore the potential of repurposed drugs across a wide range of therapeutic areas. With the growing interest in drug repurposing as a strategy to address unmet medical needs, the India drug repurposing market is expected to continue expanding in the coming years, providing opportunities for innovation and improved patient outcomes.
The drug repurposing market in India is experiencing significant growth driven by the rising demand for cost-effective solutions in drug development. With a focus on accelerating the drug discovery process and reducing time and costs, pharmaceutical companies are increasingly exploring repurposing existing drugs for new therapeutic uses. The market is witnessing collaborations between industry players, academic institutions, and government bodies to identify and repurpose drugs for various diseases, including rare diseases and infectious diseases like COVID-19. Additionally, advancements in technology, such as artificial intelligence and computational modeling, are enabling more efficient screening and identification of drug candidates for repurposing. Overall, the India drug repurposing market is poised for further expansion as stakeholders leverage innovative approaches to enhance drug discovery and development processes.
In the India drug repurposing market, challenges include regulatory hurdles related to repurposing existing drugs for new indications, limited awareness and understanding among healthcare professionals about the potential of repurposed drugs, lack of dedicated funding and incentives for drug repurposing research, and the need for robust clinical trials to establish the efficacy and safety of repurposed drugs. Additionally, there is a shortage of collaboration between academia, industry, and regulatory bodies in driving drug repurposing efforts, which hinders the efficient identification and development of new uses for existing drugs. Overcoming these challenges will require increased investment in research, improved regulatory frameworks, and enhanced collaboration within the healthcare ecosystem to fully leverage the benefits of drug repurposing in India.
The India drug repurposing market presents promising investment opportunities due to the increasing focus on finding new uses for existing drugs. This approach offers a cost-effective and efficient way to discover novel treatments for various diseases by repurposing known drugs with established safety profiles. With a growing demand for affordable healthcare solutions in India, investors can capitalize on the potential of drug repurposing to address unmet medical needs and improve patient outcomes. Additionally, the country`s strong pharmaceutical industry and expertise in drug development provide a solid foundation for driving innovation in this market segment. Investing in Indian companies specializing in drug repurposing could yield significant returns while contributing to advancements in healthcare research and drug discovery.
The Indian government has been actively promoting drug repurposing through various policies aimed at fostering innovation and accelerating the development of new treatments. Initiatives such as the National Biopharma Mission and the National Health Protection Scheme (Ayushman Bharat) have provided financial support and infrastructure for research in drug repurposing. Additionally, regulatory reforms like the New Drugs and Clinical Trials Rules 2019 have streamlined the approval process for repurposed drugs, making it easier for companies to bring these products to market. Overall, the government`s focus on promoting drug repurposing is expected to drive growth in the Indian pharmaceutical industry and improve access to affordable healthcare solutions for the population.
The India drug repurposing market is poised for significant growth in the coming years as the pharmaceutical industry continues to explore new ways to leverage existing drugs for alternative indications. With the rising costs and timelines associated with traditional drug development, drug repurposing offers a more cost-effective and efficient approach to bringing new treatments to market. Factors such as the availability of a diverse range of existing drugs, advancements in technology for drug discovery and the increasing focus on personalized medicine are expected to drive the growth of the India drug repurposing market. Additionally, the increasing prevalence of chronic diseases and the need for innovative treatment options will further fuel the demand for drug repurposing initiatives in the country. Overall, the future outlook for the India drug repurposing market appears promising with ample opportunities for growth and innovation.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Drug Repurposing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 India Drug Repurposing Market - Industry Life Cycle |
3.4 India Drug Repurposing Market - Porter's Five Forces |
3.5 India Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.6 India Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.7 India Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 India Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India |
4.2.2 Growing demand for cost-effective drug development solutions |
4.2.3 Government initiatives promoting drug repurposing research and development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug repurposing in India |
4.3.2 Limited awareness and understanding of drug repurposing among healthcare professionals |
4.3.3 Challenges in identifying suitable candidates for drug repurposing |
5 India Drug Repurposing Market Trends |
6 India Drug Repurposing Market, By Types |
6.1 India Drug Repurposing Market, By Approach |
6.1.1 Overview and Analysis |
6.1.2 India Drug Repurposing Market Revenues & Volume, By Approach, 2021 - 2031F |
6.1.3 India Drug Repurposing Market Revenues & Volume, By On-Target Repurposing, 2021 - 2031F |
6.1.4 India Drug Repurposing Market Revenues & Volume, By Off-Target Repurposing, 2021 - 2031F |
6.1.5 India Drug Repurposing Market Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031F |
6.1.6 India Drug Repurposing Market Revenues & Volume, By Pathway-Based Repurposing, 2021 - 2031F |
6.2 India Drug Repurposing Market, By Disease Area |
6.2.1 Overview and Analysis |
6.2.2 India Drug Repurposing Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 India Drug Repurposing Market Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031F |
6.2.4 India Drug Repurposing Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.5 India Drug Repurposing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3 India Drug Repurposing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Drug Repurposing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 India Drug Repurposing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.4 India Drug Repurposing Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F |
6.3.5 India Drug Repurposing Market Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031F |
6.4 India Drug Repurposing Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 India Drug Repurposing Market Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031F |
6.4.3 India Drug Repurposing Market Revenues & Volume, By High-Throughput Screening, 2021 - 2031F |
6.4.4 India Drug Repurposing Market Revenues & Volume, By Biomarker-Based Repurposing, 2021 - 2031F |
6.4.5 India Drug Repurposing Market Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2021 - 2031F |
7 India Drug Repurposing Market Import-Export Trade Statistics |
7.1 India Drug Repurposing Market Export to Major Countries |
7.2 India Drug Repurposing Market Imports from Major Countries |
8 India Drug Repurposing Market Key Performance Indicators |
8.1 Number of drug repurposing research grants awarded by government agencies |
8.2 Percentage of pharmaceutical companies investing in drug repurposing projects |
8.3 Number of successful drug repurposing cases leading to clinical trials |
8.4 Adoption rate of repurposed drugs in clinical practice |
8.5 Number of collaborations between academia, industry, and research institutions for drug repurposing initiatives |
9 India Drug Repurposing Market - Opportunity Assessment |
9.1 India Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
9.2 India Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.3 India Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 India Drug Repurposing Market - Competitive Landscape |
10.1 India Drug Repurposing Market Revenue Share, By Companies, 2024 |
10.2 India Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here